Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | PPLPHARMA Piramal Pharma Limited Pharma · Small | LALPATHLAB Dr. Lal Path Labs Ltd. Pharma · Small | NEULANDLAB Neuland Laboratories Limited Pharma · Small | PINELABS Pine Labs Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 32 | 49 | 48 | 32 |
| Verdict | WATCHLIST | FAIR VALUE | FAIR VALUE | WATCHLIST |
| Style | WATCHLIST | Premium Compounder | Financial Turnaround | WATCHLIST |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 2/30 | 0/30 | 0/30 | 2/30 |
| Growth | 9/25 | 15/25 | 17/25 | 15/25 |
| Quality | 2/20 | 15/20 | 14/20 | 0/20 |
| Balance Sheet | 10/15 | 10/15 | 8/15 | 8/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 1/10 |
| Price | ₹168.87 | ₹1,565 | ₹17,200 | ₹152.36 |
| P/E | 29.00 | 50.10 | 60.60 | 152.00 |
| P/B | 2.90 | 10.51 | 11.76 | 2.96 |
| ROE | 10.40% | 22.50% | 21.40% | 2.46% |
| ROCE | 12.10% | 28.30% | 26.60% | 4.16% |
| Debt / Equity | 0.12 | 0.08 | 0.16 | 0.07 |
| FCF Yield | 4.49% | 0.81% | — | — |
| Dividend Y | 0.08% | 0.89% | 0.20% | — |
| Altman Z | 6.05 | 9.03 | 8.27 | 2.48 |
| Promoter % | 34.85% | 53.21% | 32.63% | — |
| Mkt Cap (₹Cr) | 22474.00 | 26422.00 | 22057.00 | 17483.00 |
| Graham # | ₹83.07 | ₹318.89 | ₹3,053.89 | ₹33.63 |
| Fair PE | 19.1 | 42.0 | 42.0 | 42.0 |
| MoS % | -67.7% | -23.7% | -44.4% | -270.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startPPLPHARMA60
LALPATHLAB51
NEULANDLAB125
PINELABS61